|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,384.00 JPY | -2.99% |
|
-2.09% | +9.74% |
| 01:18am | Ono Pharmaceutical's Profit Rises 37% in Fiscal Q1 | MT |
| 07-28 | Ono Pharmaceutical Co., Ltd. Partners with Phylo, Inc. to Embed Agentic AI with Every Discovery Scientist | CI |
| Market Cap | 1,155B 7.24B 6.29B 5.84B 5.39B 10.15B 691B 10.33B 69.16B 27.08B 343B 27.2B 26.6B | P/E 2027 * |
16.3x | P/E 2028 * | 18.5x |
|---|---|---|---|---|---|
| Enterprise Value | 956B 5.99B 5.21B 4.83B 4.46B 8.4B 572B 8.55B 57.23B 22.41B 284B 22.51B 22.01B | EV / Sales 2027 * |
2.1x | EV / Sales 2028 * | 2.11x |
| Free-Float |
80.98% | Yield 2027 * |
3.19% | Yield 2028 * | 3.15% |
Last Transcript: Ono Pharmaceutical Co., Ltd.
| 1 day | -2.99% | ||
| 1 week | -2.09% | ||
| Current month | -0.17% | ||
| 1 month | +0.68% | ||
| 3 months | +2.96% | ||
| 6 months | +0.10% | ||
| Current year | +9.74% |
| 1 week | 2,324 |  | 2,514.5 |
| 1 month | 2,324 | | 2,514.5 |
| Current year | 2,114.5 | | 2,674.5 |
| 1 year | 1,596 | | 2,674.5 |
| 3 years | 1,474 | | 2,966.5 |
| 5 years | 1,474 | | 3,990 |
| 10 years | 1,474 | | 3,990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 67 | 2024-03-31 |
Masaki Ito
DFI | Director of Finance/CFO | - | 2026-03-31 |
Toichi Takino
PSD | President | 57 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gyo Sagara
CHM | Chairman | 67 | 2024-03-31 |
Toichi Takino
BRD | Director/Board Member | 57 | 2020-05-31 |
Masao Nomura
BRD | Director/Board Member | 76 | 2018-06-25 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.99% | -2.09% | +41.02% | -8.36% | 7.24B | |
| +2.08% | +4.53% | +17.81% | +78.64% | 50.29B | |
| -1.81% | -0.49% | +51.99% | +112.44% | 37.24B | |
| +0.71% | +6.02% | -5.29% | +25.69% | 12.41B | |
| +0.71% | +0.82% | +12.84% | +77.60% | 11.65B | |
| +0.38% | +0.96% | +31.25% | +132.30% | 9.17B | |
| +0.51% | +1.03% | +14.16% | +32.55% | 6.8B | |
| +2.08% | +1.23% | +3.65% | +183.34% | 6.47B | |
| +0.21% | -5.18% | -34.40% | -1.46% | 5.46B | |
| +0.35% | +0.24% | +23.12% | +103.16% | 4.5B | |
| Average | +0.18% | +1.90% | +15.62% | +73.59% | 15.12B | |
| Weighted average by Cap. | +0.35% | +2.69% | +23.38% | +81.87% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 454B 2.85B 2.47B 2.3B 2.12B 3.99B 272B 4.06B 27.21B 10.65B 135B 10.7B 10.47B | 444B 2.79B 2.42B 2.25B 2.07B 3.91B 266B 3.98B 26.62B 10.42B 132B 10.47B 10.24B |
| Net income | 70.98B 445M 387M 359M 331M 624M 42.5B 635M 4.25B 1.66B 21.11B 1.67B 1.64B | 62.51B 392M 341M 316M 292M 549M 37.43B 559M 3.74B 1.47B 18.59B 1.47B 1.44B |
| Net Debt | -199B -1.25B -1.09B -1.01B -929M -1.75B -119B -1.78B -11.93B -4.67B -59.24B -4.69B -4.59B | -218B -1.37B -1.19B -1.1B -1.02B -1.92B -131B -1.95B -13.07B -5.12B -64.89B -5.14B -5.03B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-31 | JP¥2,384.00 | -2.99% | 3,274,400 |
| 26-07-30 | JP¥2,457.50 | -1.36% | 1,852,100 |
| 26-07-29 | JP¥2,491.50 | +3.08% | 2,326,700 |
| 26-07-28 | JP¥2,417.00 | -0.92% | 1,462,400 |
| 26-07-27 | JP¥2,439.50 | +0.18% | 1,568,600 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 4528 Stock
Select your edition
All financial news and data tailored to specific country editions
